Literature DB >> 23986601

Comparative analysis of the complete genome sequence of the California MSW strain of myxoma virus reveals potential host adaptations.

Peter J Kerr1, Matthew B Rogers, Adam Fitch, Jay V Depasse, Isabella M Cattadori, Peter J Hudson, David C Tscharke, Edward C Holmes, Elodie Ghedin.   

Abstract

Myxomatosis is a rapidly lethal disease of European rabbits that is caused by myxoma virus (MYXV). The introduction of a South American strain of MYXV into the European rabbit population of Australia is the classic case of host-pathogen coevolution following cross-species transmission. The most virulent strains of MYXV for European rabbits are the Californian viruses, found in the Pacific states of the United States and the Baja Peninsula, Mexico. The natural host of Californian MYXV is the brush rabbit, Sylvilagus bachmani. We determined the complete sequence of the MSW strain of Californian MYXV and performed a comparative analysis with other MYXV genomes. The MSW genome is larger than that of the South American Lausanne (type) strain of MYXV due to an expansion of the terminal inverted repeats (TIRs) of the genome, with duplication of the M156R, M154L, M153R, M152R, and M151R genes and part of the M150R gene from the right-hand (RH) end of the genome at the left-hand (LH) TIR. Despite the extreme virulence of MSW, no novel genes were identified; five genes were disrupted by multiple indels or mutations to the ATG start codon, including two genes, M008.1L/R and M152R, with major virulence functions in European rabbits, and a sixth gene, M000.5L/R, was absent. The loss of these gene functions suggests that S. bachmani is a relatively recent host for MYXV and that duplication of virulence genes in the TIRs, gene loss, or sequence variation in other genes can compensate for the loss of M008.1L/R and M152R in infections of European rabbits.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23986601      PMCID: PMC3807925          DOI: 10.1128/JVI.01923-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  The complete DNA sequence of myxoma virus.

Authors:  C Cameron; S Hota-Mitchell; L Chen; J Barrett; J X Cao; C Macaulay; D Willer; D Evans; G McFadden
Journal:  Virology       Date:  1999-11-25       Impact factor: 3.616

2.  Leporipoxvirus Cu-Zn superoxide dismutase homologs inhibit cellular superoxide dismutase, but are not essential for virus replication or virulence.

Authors:  Jing Xin Cao; Melissa L T Teoh; Mijin Moon; Grant McFadden; David H Evans
Journal:  Virology       Date:  2002-04-25       Impact factor: 3.616

3.  MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods.

Authors:  Koichiro Tamura; Daniel Peterson; Nicholas Peterson; Glen Stecher; Masatoshi Nei; Sudhir Kumar
Journal:  Mol Biol Evol       Date:  2011-05-04       Impact factor: 16.240

4.  Characterization and functional analysis of Serp3: a novel myxoma virus-encoded serpin involved in virulence.

Authors:  Jean-Luc Guerin; Jacqueline Gelfi; Christelle Camus; Maxence Delverdier; James C Whisstock; Marie-France Amardeihl; Robert Py; Stéphane Bertagnoli; Frédérique Messud-Petit
Journal:  J Gen Virol       Date:  2001-06       Impact factor: 3.891

Review 5.  Myxomatosis in Australia and Europe: a model for emerging infectious diseases.

Authors:  Peter J Kerr
Journal:  Antiviral Res       Date:  2012-02-08       Impact factor: 5.970

6.  First report of myxomatosis in Mexico.

Authors:  R M Licón Luna
Journal:  J Wildl Dis       Date:  2000-07       Impact factor: 1.535

7.  Myxoma virus immunomodulatory protein M156R is a structural mimic of eukaryotic translation initiation factor eIF2alpha.

Authors:  Theresa A Ramelot; John R Cort; Adelinda A Yee; Furong Liu; Michael B Goshe; Aled M Edwards; Richard D Smith; Cheryl H Arrowsmith; Thomas E Dever; Michael A Kennedy
Journal:  J Mol Biol       Date:  2002-10-04       Impact factor: 5.469

8.  RATT: Rapid Annotation Transfer Tool.

Authors:  Thomas D Otto; Gary P Dillon; Wim S Degrave; Matthew Berriman
Journal:  Nucleic Acids Res       Date:  2011-02-08       Impact factor: 16.971

Review 9.  The current status and future directions of myxoma virus, a master in immune evasion.

Authors:  Bart Spiesschaert; Grant McFadden; Katleen Hermans; Hans Nauwynck; Gerlinde R Van de Walle
Journal:  Vet Res       Date:  2011-06-09       Impact factor: 3.683

10.  Evolutionary history and attenuation of myxoma virus on two continents.

Authors:  Peter J Kerr; Elodie Ghedin; Jay V DePasse; Adam Fitch; Isabella M Cattadori; Peter J Hudson; David C Tscharke; Andrew F Read; Edward C Holmes
Journal:  PLoS Pathog       Date:  2012-10-04       Impact factor: 6.823

View more
  14 in total

1.  Myxoma virus M156 is a specific inhibitor of rabbit PKR but contains a loss-of-function mutation in Australian virus isolates.

Authors:  Chen Peng; Sherry L Haller; Masmudur M Rahman; Grant McFadden; Stefan Rothenburg
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-22       Impact factor: 11.205

Review 2.  Viral biocontrol: grand experiments in disease emergence and evolution.

Authors:  Francesca Di Giallonardo; Edward C Holmes
Journal:  Trends Microbiol       Date:  2014-10-31       Impact factor: 17.079

3.  Genetic Variability of Myxoma Virus Genomes.

Authors:  Christoph Braun; Andrea Thürmer; Rolf Daniel; Anne-Kathrin Schultz; Ingo Bulla; Horst Schirrmeier; Dietmar Mayer; Andreas Neubert; Claus-Peter Czerny
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

Review 4.  Species-Specific Host-Virus Interactions: Implications for Viral Host Range and Virulence.

Authors:  Stefan Rothenburg; Greg Brennan
Journal:  Trends Microbiol       Date:  2019-10-06       Impact factor: 17.079

5.  Punctuated Evolution of Myxoma Virus: Rapid and Disjunct Evolution of a Recent Viral Lineage in Australia.

Authors:  Peter J Kerr; John-Sebastian Eden; Francesca Di Giallonardo; David Peacock; June Liu; Tanja Strive; Andrew F Read; Edward C Holmes
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

6.  Genome scale evolution of myxoma virus reveals host-pathogen adaptation and rapid geographic spread.

Authors:  Peter J Kerr; Matthew B Rogers; Adam Fitch; Jay V Depasse; Isabella M Cattadori; Alan C Twaddle; Peter J Hudson; David C Tscharke; Andrew F Read; Edward C Holmes; Elodie Ghedin
Journal:  J Virol       Date:  2013-09-25       Impact factor: 5.103

7.  Reverse Engineering Field Isolates of Myxoma Virus Demonstrates that Some Gene Disruptions or Losses of Function Do Not Explain Virulence Changes Observed in the Field.

Authors:  June Liu; Isabella M Cattadori; Derek G Sim; John-Sebastian Eden; Edward C Holmes; Andrew F Read; Peter J Kerr
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

Review 8.  Myxoma virus and the Leporipoxviruses: an evolutionary paradigm.

Authors:  Peter J Kerr; June Liu; Isabella Cattadori; Elodie Ghedin; Andrew F Read; Edward C Holmes
Journal:  Viruses       Date:  2015-03-06       Impact factor: 5.048

9.  The α2,3-sialyltransferase encoded by myxoma virus is a virulence factor that contributes to immunosuppression.

Authors:  Bérengère Boutard; Sophie Vankerckhove; Nicolas Markine-Goriaynoff; Mickaël Sarlet; Daniel Desmecht; Grant McFadden; Alain Vanderplasschen; Laurent Gillet
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

Review 10.  Poxviruses in bats … so what?

Authors:  Kate S Baker; Pablo R Murcia
Journal:  Viruses       Date:  2014-04-03       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.